NxStage Medical (NXTM) Reports Q4 Loss of $0.21, Beats by 6c; Guides Q1, FY09
Tweet Send to a Friend
NxStage Medical, Inc. (Nasdaq: NXTM) reports Q4 loss of $0.21, 6 cents better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
